TCF11/NRF1 Antibody [F22N18]

N.º de catálogo F0861

Imprimir

Descripción biológica

Especificidad TCF11/NRF1 Antibody [F22N18] detecta niveles endógenos de la proteína total TCF11/NRF1.
Antecedentes TCF11, también conocido como NRF1 (factor nuclear eritroide 2-relacionado 1), es un factor de transcripción CNC-bZIP (Cap'n'collar basic leucine zipper) perteneciente a la familia Nrf, expresado de forma ubicua en los tejidos y existente como múltiples isoformas, incluyendo una forma unida a la membrana del RE de 120 kDa y una variante truncada nuclear de 65 kDa. TCF11 presenta un dominio bZIP para la unión al ADN de los elementos de respuesta antioxidante (AREs), Neh1L (dominio CNC con bZIP), Neh2L (degrón similar a ETGE/Neh2 para la interacción con Keap1), Neh4L/Neh5L (dominios de transactivación) y Neh6L (con motivos ricos en serina para la fosforilación de GSK3 y la degradación mediada por CRL3), junto con dominios N-terminales ácidos sensibles a la glucosa y de direccionamiento al RE que permiten la repartición topológica. TCF11 se transloca del RE al núcleo tras la inhibición del proteasoma a través de la retrotranslocación dependiente de p97/VCP y el procesamiento proteolítico, donde se heterodimeriza con pequeñas proteínas Maf para unirse a los AREs e inducir transcripcionalmente los genes de las subunidades del proteasoma (por ejemplo, PSMB5-8), restaurando la capacidad proteolítica y mitigando el estrés proteotóxico. Este mecanismo también regula los genes de la biogénesis mitocondrial, las respuestas al estrés oxidativo a través de GCLC y la citoprotección contra el daño inducido por rotenona, ejerciendo TCF11 efectos supresores tumorales más fuertes que Nrf1α al regular al alza los genes de supervivencia en el carcinoma hepatocelular. La desregulación vincula a TCF11 con la neurodegeneración y la progresión del cáncer debido a una homeostasis redox/proteostasis alterada.

Información de uso

Aplicación WB Dilución
WB
1:1000
Reactividad Human, Mouse, Monkey
Fuente Rabbit Monoclonal Antibody MW 120-140 kDa
Tampón de almacenamiento PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
Almacenamiento
(Desde la fecha de recepción)
-20°C (avoid freeze-thaw cycles), 2 years
WB
Experimental Protocol:
 
Sample preparation
1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
5. Take a small amount of the lysate to determine the protein concentration;
Electrophoretic separation
1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 5%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
 
Transfer membrane
1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
Recommended conditions for wet transfer: 200 mA, 120 min.
( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
 
Block
1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
2. Incubate the film in the blocking solution for 1 hour at room temperature;
3. Wash the film with TBST for 3 times, 5 minutes each time.
 
Antibody incubation
1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
2. Wash the film with TBST 3 times, 5 minutes each time;
3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
 
Antibody staining
1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

Referencias

  • https://pubmed.ncbi.nlm.nih.gov/34268128/
  • https://pubmed.ncbi.nlm.nih.gov/24695487/

Datos de aplicación

WB

Validado por Selleck

  • F0861-wb
    Lane 1: U-2 OS, Lane 2: U-2 OS (MG132, 10 µM, 8 h)